Login / Signup

A Case of Corticobasal Syndrome and Posterior Cortical Atrophy With Biomarkers of Alzheimer Disease.

Yoko SugimuraToru BabaMichinori EzuraAkio KikuchiTakafumi HasegawaIsao NaganoKyoko SuzukiAtsushi Takeda
Published in: Alzheimer disease and associated disorders (2023)
Corticobasal syndrome is a clinical entity characterized by asymmetric akinetic rigidity and a variety of higher cortical dysfunction. Predicting background pathology of corticobasal syndrome is rather challenging; however, clinical and neuroimaging findings may provide a clue to its etiopathological origin. Visuospatial dysfunction of posterior cortical atrophy and logopenic-type language impairment indicate the presence of Alzheimer's disease-related pathology, and they provide useful information in distinguishing Alzheimer's disease from other types of corticobasal syndrome. Here we describe a case of corticobasal syndrome who showed characteristic visuospatial symptoms with imaging evidence of Alzheimer's disease supported by amyloid-PET and tau/astrogliosis-PET. Early, accurate diagnosis based on clinical features and predictable biomarkers is mandatory to the success of early intervention in corticobasal syndrome associated with Alzheimer's disease.
Keyphrases
  • case report
  • cognitive decline
  • high resolution
  • healthcare
  • mild cognitive impairment
  • mass spectrometry
  • pet ct
  • autism spectrum disorder
  • depressive symptoms
  • sleep quality
  • cerebrospinal fluid
  • drug induced